Table 1.
Demographic and clinical characteristics of the MRP group and the MSP group.
| Measures | MRP n = 14 | MSP n = 15 | P-value |
|---|---|---|---|
| Ages | 61.0 (7.0) | 62.6 (8.3) | 0.58a |
| Males/Females | 8/6 | 5/10 | 0.20b |
| Duration | 14.3 (7.6) | 9.0 (7.4) | 0.07a |
| Pre-VAS | 6.9 (1.1) | 6.1 (1.4) | 0.09a |
| Post-VAS | 6.9 (1.5) | 2.4 (0.6) | <0.0001a |
| Pre-PSQI | 8.9 (3.7) | 8.4 (5.7) | 0.76a |
| Post-PSQI | 7.4 (3.9) | 3.7 (1.6) | 0.004a |
Data are presented as mean (standard deviation). MRP, medication-resistant pain; MSP, medication-sensitive pain; VAS, visual analog scale; Pre-VAS, pre-scanning VAS; Post-VAS, post-treatment VAS; Pre-PSQI, Pittsburgh sleep quality index before treatment; Post-PSQI, Pittsburgh sleep quality index after treatment. atwo-sample t-test; bChi-square test.